DR Horton Stock BOERSE MUENCHEN

Equities

HO2

US23331A1097

Homebuilding

Real-time BOERSE MUENCHEN 05:44:18 2024-06-13 EDT 5-day change 1st Jan Change
132.1 EUR -0.50% Intraday chart for DR Horton -0.51% -2.92%

Financials

Sales 2024 * 36.93B 34.17B 50.74B Sales 2025 * 39.4B 36.46B 54.14B Capitalization 47.33B 43.8B 65.04B
Net income 2024 * 4.72B 4.37B 6.49B Net income 2025 * 5B 4.63B 6.88B EV / Sales 2024 * 1.32 x
Net Debt 2024 * 1.36B 1.26B 1.87B Net Debt 2025 * 1.02B 944M 1.4B EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
10.1 x
P/E ratio 2025 *
9.25 x
Employees -
Yield 2024 *
0.83%
Yield 2025 *
0.9%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 week-0.51%
Current month-1.40%
1 month-4.60%
3 months-6.64%
6 months+2.39%
Current year-2.92%
More quotes
1 week
128.22
Extreme 128.22
137.50
1 month
128.22
Extreme 128.22
145.72
3 years
57.21
Extreme 57.21
152.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Chairman 68 87-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
Director/Board Member 73 21-04-19
More insiders
Date Price Change
24-06-13 132.1 -0.50%
24-06-12 132.8 +1.70%
24-06-11 130.6 -0.96%
24-06-10 131.8 +0.86%
24-06-07 130.7 -0.97%

Real-time BOERSE MUENCHEN, June 13, 2024 at 05:44 am

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
143.7 USD
Average target price
169.8 USD
Spread / Average Target
+18.14%
Consensus